Tissue-Engineered Neural Stem Cell Scaffolds in Spinal Cord Injury: Insights into Materials, Molecular Pathways, and Regenerative Applications

Authors

  • ahmed

    Biomedical Sciences Department, College of Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates
  • Jim Schank

    Neuroscience Research Center, University of Gorgia, Athene, GA 30601, USA
  • Mark M. Rohn

    Biochemistry & Molecular Biology Department, Medical research institutes in Texas‎, Austin, TX 78712, USA
  • Asim S. Khan

    Department of Pharmacotherapeutics, College of Pharmacy, Immam Abdulrahman University, Dmmam 8273, Saudi Arabia
  • Ehab M. Hantash

    Neonatal Intensive Care Unit, Dr. Suliman Al Habib Medical Group, Riyadh 11635, Saudi Arabia

    Anatomy and embryology Department, College of Medicine, Tanta university, Tanta 31511, Egypt
  • Liju S. Mathew

    Biomedical Sciences Department, College of Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates

DOI:

https://doi.org/10.30564/jscb.v1i1.9529
Received: 23 April 2025 | Revised: 12 MAY 2025 | Accepted: 21 MAY 2025 | Published Online: 15 June 2025

Abstract

Spinal cord injury (SCI) poses significant regenerative challenges because the central nervous system (CNS) has a limited intrinsic ability to repair itself after damage. The complex nature of SCI, including neuronal loss, glial scarring, and disrupted neural pathways, makes effective treatment difficult. In recent years, stem cell–based scaffolds have emerged as a promising therapeutic strategy aimed at facilitating functional recovery. These scaffolds provide a supportive three-dimensional (3D) structure that closely mimics the natural extracellular matrix (ECM) of the spinal cord. This biomimetic environment plays a crucial role in enhancing the differentiation of neural stem cells (NSCs). By guiding NSC behavior and integration into the injured spinal tissue, these scaffolds can help restore some degree of neural function. The synergy between stem cells and engineered scaffolds offers a multifaceted approach to spinal cord regeneration and holds substantial potential for clinical applications. A variety of biomaterials including natural and synthetic polymers, as well as hydrogels, have been developed for this purpose, often enhanced by growth factors, neurotrophic agents, and electrical stimulation to boost axonal regeneration and remyelination. Key signaling pathways like Notch, Wnt/β-catenin, Shh, and BMP play a role in guiding NSC differentiation and are being explored as therapeutic targets. Preclinical studies have shown functional improvements with scaffold-assisted cell delivery, and early clinical trials using collagen scaffolds with umbilical cord–derived MSCs show promising results. However, challenges such as immune response, scaffold degradation, and cost remain, highlighting the need for further research to ensure safe and effective clinical application.

Keywords:

Neural Stem Cells; Stem Therapy; Neurotrophic Factors; Polyethylene Glycol; Collagen Scaffolds; Spinal Cord Injury Repair

References

[1] Yang, Y., Akdemir, A.R., Rashik, R.A., et al., 2025. Guided neural stem cell differentiation by dynamic loading of 3D printed elastomeric scaffolds. Journal of the mechanical behavior of biomedical materials. 165, 106940. DOI: https://doi.org/10.1016/j.jmbbm.2025.106940

[2] Zhao, J. Y., Wang, W., Yin, Z., Hou, L. S., Zhang, Y. W., Cai, Z., Guan, Y., Wang, J., & Zhang, B. L. (2025). Injectable thermosensitive hydrogel system based on hyaluronic acid and methylcellulose for the synergistic therapy of traumatic spinal cord injury. International journal of biological macromolecules, 144629. Advance online publication. https://doi.org/10.1016/j.ijbiomac.2025.144629

[3] Yang, L., Cao, J., Du, Y., et al., 2024. Initial IL-10 production dominates the therapy of mesenchymal stem cell scaffold in spinal cord injury. Theranostics. 14(2), 879–891. DOI: https://doi.org/10.7150/thno.87843

[4] Yun, D., Lee, Y.M., Laughter, M.R., et al., 2015. Substantial Differentiation of Human Neural Stem Cells Into Motor Neurons on a Biomimetic Polyurea. Macromolecular bioscience. 15(9), 1206–1211. DOI: https://doi.org/10.1002/mabi.201500066

[5] Li, H., Chen, S., Dissanayaka, W.L., et al., 2024. Gelatin Methacryloyl/Sodium Alginate/Cellulose Nanocrystal Inks and 3D Printing for Dental Tissue Engineering Applications. ACS omega. 9(49), 48361–48373. DOI: https://doi.org/10.1021/acsomega.4c06458

[6] Narita, T., Hsieh, W.C., Ku, Y.T., et al., 2025. Fracture Behavior and Biocompatibility of Cellulose Nanofiber-Reinforced Poly(vinyl alcohol) Composite Hydrogels Cross-Linked with Borax. Biomacromolecules. 26(1), 374–386. DOI: https://doi.org/10.1021/acs.biomac.4c01199

[7] da Silva, G.R., Song, E., Chen, K.M., et al., 2025. Gelatin nanofibers coated with hyaluronic acid as a mesenchymal stromal cell scaffold for corneal regeneration. International journal of pharmaceutics. 669, 125009. DOI: https://doi.org/10.1016/j.ijpharm.2024.125009

[8] Nakanishi, J., Ueki, T., Dieb, S., et al., 2024. Data-driven optimization of the in silico design of ionic liquids as interfacial cell culture fluids. Science and technology of advanced materials. 25(1), 2418287. DOI: https://doi.org/10.1080/14686996.2024.2418287

[9] Barcena, A.J.R., Mishra, A., Bolinas, D.K.M., et al., 2024. Integration of Electrospun Scaffolds and Biological Polymers for Enhancing the Delivery and Efficacy of Mesenchymal Stem/Stromal Cell Therapies. Frontiers in bioscience (Landmark edition). 29(6), 228. DOI: https://doi.org/10.31083/j.fbl2906228

[10] Jeon, J., Park, S.H., Choi, J., et al., 2024. Association between neural stem/progenitor cells and biomaterials in spinal cord injury therapies: A systematic review and network meta-analysis. Acta biomaterialia. 183, 50–60. DOI: https://doi.org/10.1016/j.actbio.2024.06.011

[11] Li, C., Shan, Y., Zheng, S., Tan, P., Bai, Y., Wang, E., Xu, L., Luo, R., Chao, S., Huang, J., Ren, P., Li, Z., & Feng, H. (2025). Nanogenerator Neuromodulation to Enable Locomotion Rehabilitation for Spinal Cord Injury via Epidural Electrical Stimulation. Advanced science (Weinheim, Baden-Wurttemberg, Germany), e2501425. Advance online publication. https://doi.org/10.1002/advs.202501425

[12] Wang, X., Wang, M., Xu, Y., et al., 2024. A 3D-printable gelatin/alginate/ε-poly-l-lysine hydrogel scaffold to enable porcine muscle stem cells expansion and differentiation for cultured meat development. International journal of biological macromolecules. 271(Pt 1), 131980. DOI: https://doi.org/10.1016/j.ijbiomac.2024.131980

[13] Troiani, Z., Chipman, D. E., Ryan, T. J., Haider, M. N., Kowalski, D., Hasanspahic, B., Scott, M. M., Vallee, E. K., & Lucasti, C. (2025). Efficacy of Mesenchymal and Embryonic Stem Cell Therapy for the Treatment of Spinal Cord Injury: A Systematic Review and Meta-Analysis of Human Studies. Global spine journal, 21925682251345450. Advance online publication. https://doi.org/10.1177/21925682251345450

[14] Wang, X., Zhou, Z., Zhang, Y., et al., 2025. Exosome-shuttled miR-5121 from A2 astrocytes promotes BSCB repair after traumatic SCI by activating autophagy in vascular endothelial cells. Journal of nanobiotechnology. 23(1), 291. DOI: https://doi.org/10.1186/s12951-025-03365-3

[15] Esposito, E., Paterniti, I., Mazzon, E., et al., 2025. Retraction Note: MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma. BMC neuroscience. 26(1), 28. DOI: https://doi.org/10.1186/s12868-025-00949-5

[16] Valido, E., Bertolo, A., Wöllner, J., et al., 2025. Effects of Uro-Vaxom vs. placebo on the urinary tract microbiome in individuals with spinal cord injury in a randomized controlled pilot trial (Uro-Vaxom pilot). Scientific reports. 15(1), 12825. DOI: https://doi.org/10.1038/s41598-025-96939-y

[17] Robles, L., Eversman, H., Chua, R.V., 2025. Chiari malformation type I with an associated syrinx presenting as acute central cord syndrome in a child: illustrative case. Journal of neurosurgery. Case lessons. 9(15), CASE24829. DOI: https://doi.org/10.3171/CASE24829

[18] Zhang, Z.Y., Zhang, T., Gao, L., et al., 2025. Brown-Sequard syndrome caused by posterior full-endoscopic cervical discectomy: A case report. Medicine. 104(15), e42007. DOI: https://doi.org/10.1097/MD.0000000000042007

[19] Pessoa C., 2025. Enhancing Self-Management Support Apps for Spinal Cord Injury: The Missing Role of Caregivers. JMIR mHealth and uHealth. 13, e72037. DOI: https://doi.org/10.2196/72037

[20] Vaikuntam, B.P., Sharwood, L.N., Connelly, L.B., et al., 2025. Economic Optimization Through Adherence to Best Practice Guidelines: A Decision Analysis of Traumatic Spinal Cord Injury Care Pathways in Australia. Journal of Neurotrauma. DOI: https://doi.org/10.1089/neu.2023.0674

[21] Yu, C., Wang, J., Wang, J., et al., 2025. Impact of ultra-early, early and delayed decompression on neurological and clinical outcomes in spinal cord injury: A systematic review and meta-analysis. The journal of spinal cord medicine. 1–10. DOI: https://doi.org/10.1080/10790268.2025.2483074

[22] Cusimano, M., Tom, V.J., Houle, J.D., et al., 2025. Passive Hindlimb Cycling Enhances Tolerance of Cardiac Electrical Conduction in Rats with Spinal Cord Injuries. Journal of Neurotrauma. DOI: https://doi.org/10.1089/neu.2025.0021

[23] Al-Karagholi, M.A., Zhuang, Z.A., Beich, S., et al., 2025. PACAP38-induced migraine attacks are independent of CGRP signaling: a randomized controlled trial. The journal of headache and pain. 26(1), 79. DOI: https://doi.org/10.1186/s10194-025-02022-2

[24] Liu, Z., Wang, L., Yu, L., et al., 2025. Identification of immune cells and circulating inflammatory factors associated with neurodevelopmental disorders by bidirectional Mendelian randomization and mediation analysis. Scientific reports. 15(1), 12840. DOI: https://doi.org/10.1038/s41598-025-98020-0

[25] Xu, J., Chen, X., Zhang, H., et al., 2025. Platelet-rich plasma relieves inflammation and pain by regulating M1/M2 macrophage polarization in knee osteoarthritis rats. Scientific reports. 15(1), 12805. DOI: https://doi.org/10.1038/s41598-025-97501-6

[26] Kim, D.Y., Leem, Y.H., Kim, H.S., 2025. MLKL Inhibitor Reduces Oxidative Stress, Inflammation, and Dopaminergic Neuronal Cell Death in MPTP-Induced Parkinson's Disease Mouse Model. Biomolecules & therapeutics. DOI: https://doi.org/10.4062/biomolther.2025.049

[27] Ramachandran, S., Thangarajan, S., 2025. Thymoquinone-loaded solid lipid nanoparticles mitigate 3-Nitropropionic acid-induced mitochondrial dysfunction and oxidative damage via regulating PGC-1α/Nrf2 pathway. Neurotoxicology. DOI: https://doi.org/10.1016/j.neuro.2025.04.005

[28] Yuping, Z., Tianbi, L., Wentao, S., et al., 2024. The Optimal Type and Dose of Exercise for Elevating Brain-Derived Neurotrophic Factor Levels in Patients With Depression: A Systematic Review With Pairwise, Network, and Dose-Response Meta-Analyses. Depression and anxiety. 2024, 5716755. DOI: https://doi.org/10.1155/da/5716755

[29] Cong, L., Ding, S., Guo, Y., wt al., 2025. Acupuncture alleviates CSDS-induced depressive-like behaviors by modulating synaptic plasticity in vCA1. Theranostics. 15(10), 4808–4822. DOI: https://doi.org/10.7150/thno.106751

[30] Ugalde-Triviño, L., Tejeda, G.S., Esteban-Ortega, G.M., et al., 2025. A brain-accessible peptide modulates stroke inflammatory response and neurotoxicity by targeting BDNF-receptor TrkB-T1 specific interactome. Theranostics. 15(10), 4654–4672. DOI: https://doi.org/10.7150/thno.111272

[31] Wang, W.N., Zhang, X.L., Xie, J.F., et al., 2025. Associations of serum MANF with severity and prognosis in community-acquired pneumonia patients. Scientific reports. 15(1), 12702. DOI: https://doi.org/10.1038/s41598-025-97841-3

[32] Ortolá, R., Sotos-Prieto, M., Carballo, A., et al., 2025. Role of Serum Brain-Derived Neurotrophic Factor as a Biomarker of Chronic Pain in Older Adults. European journal of pain (London, England). 29(5), e70014. DOI: https://doi.org/10.1002/ejp.70014

[33] de Freria, C.M., Van Niekerk, E., Blesch, A., et al., 2021. Neural Stem Cells: Promoting Axonal Regeneration and Spinal Cord Connectivity. Cells. 10(12), 3296. DOI: https://doi.org/10.3390/cells10123296

[34] Kawai, M., Imaizumi, K., Ishikawa, M., et al., 2021. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function. Cell reports. 37(8), 110019. DOI: https://doi.org/10.1016/j.celrep.2021.110019

[35] Xue, W., Fan, C., Chen, B., et al., 2021. Direct neuronal differentiation of neural stem cells for spinal cord injury repair. Stem cells (Dayton, Ohio). 39(8), 1025–1032. DOI: https://doi.org/10.1002/stem.3366

[36] Yamazaki, K., Kawabori, M., Seki, T., et al., 2020. Clinical Trials of Stem Cell Treatment for Spinal Cord Injury. International journal of molecular sciences. 21(11), 3994. DOI: https://doi.org/10.3390/ijms21113994

[37] Sabelström, H., Stenudd, M., Frisén, J., 2014. Neural stem cells in the adult spinal cord. Experimental neurology. 260, 44–49. DOI: https://doi.org/10.1016/j.expneurol.2013.01.026

[38] Fan, B., Wei, Z., Yao, X., et al., 2018. Microenvironment Imbalance of Spinal Cord Injury. Cell transplantation. 27(6), 853–866. DOI: https://doi.org/10.1177/0963689718755778

[39] Jin, L.Y., Li, J., Wang, K.F., et al., 2021. Blood-Spinal Cord Barrier in Spinal Cord Injury: A Review. Journal of neurotrauma. 38(9), 1203–1224. DOI: https://doi.org/10.1089/neu.2020.7413

[40] Yousefifard, M., Askarian-Amiri, S., Nasseri Maleki, S., et al., 2022. Combined application of neural stem/progenitor cells and scaffolds on locomotion recovery following spinal cord injury in rodents: a systematic review and meta-analysis. Neurosurgical review. 45(6), 3469–3488. DOI: https://doi.org/10.1007/s10143-022-01859-4

[41] Mothe, A.J., Tator, C.H., 2013. Review of transplantation of neural stem/progenitor cells for spinal cord injury. International journal of developmental neuroscience. 31(7), 701–713. DOI: https://doi.org/10.1016/j.ijdevneu.2013.07.004

[42] Hugnot J.P., 2022. Isolate and Culture Neural Stem Cells from the Mouse Adult Spinal Cord. In: Clifton, N.J. (eds.). Neural Progenitor Cells: Methods and Protocols. Humana Press: New York, NY, USA. pp. 45–56.

[43] Son, D., Zheng, J., Kim, I.Y., et al., 2023. Human induced neural stem cells support functional recovery in spinal cord injury models. Experimental & molecular medicine. 55(6), 1182–1192. DOI: https://doi.org/10.1038/s12276-023-01003-2

[44] Venkatesh, K., Ghosh, S.K., Mullick, M., et al., 2019. Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications. Cell and tissue research. 377(2), 125–151. DOI: https://doi.org/10.1007/s00441-019-03039-1

[45] Sun, Z., Chen, Z., Yin, M., et al., 2024. Harnessing developmental dynamics of spinal cord extracellular matrix improves regenerative potential of spinal cord organoids. Cell stem cell. 31(5), 772–787.e11. DOI: https://doi.org/10.1016/j.stem.2024.03.007

[46] Park, Y.M., Kim, J.H., Lee, J.E., 2022. Neural Stem Cells Overexpressing Arginine Decarboxylase Improve Functional Recovery from Spinal Cord Injury in a Mouse Model. International journal of molecular sciences. 23(24), 15784. DOI: https://doi.org/10.3390/ijms232415784

[47] Santos, S.I.P., de Oliveira, V.C., Pieri, N.C.G., et al., 2021. Isolation and characterization of neural stem cells from fetal canine spinal cord. Neuroscience letters. 765, 136293. DOI: https://doi.org/10.1016/j.neulet.2021.136293

[48] Stenudd, M., Sabelström, H., Llorens-Bobadilla, E., et al., 2022. Identification of a discrete subpopulation of spinal cord ependymal cells with neural stem cell properties. Cell reports. 38(9), 110440. DOI: https://doi.org/10.1016/j.celrep.2022.110440

[49] Zhao, T., Liu, C., Liu, L., et al., 2023. Aging-accelerated differential production and aggregation of STAT3 protein in neuronal cells and neural stem cells in the male mouse spinal cord. Biogerontology. 24(1), 137–148. DOI: https://doi.org/10.1007/s10522-022-10004-z

[50] Tang, X., Yu, M., Liao, C., et al., 2021. Induced neural stem cells-derived spinal cord progenitor cells as stable stage for rapid and efficient generation of human oligodendrocytes and motor neurons. Connective tissue research. 62(2), 206–214. DOI: https://doi.org/10.1080/03008207.2019.1670651

[51] Sun, C., Sha, S., Shan, Y., et al., 2025. Intranasal Delivery of BACE1 siRNA and Berberine via Engineered Stem Cell Exosomes for the Treatment of Alzheimer's Disease. International journal of nanomedicine. 20, 5873–5891. DOI: https://doi.org/10.2147/IJN.S506793

[52] Han, C., Jiao, J., Gong, C., et al., 2025. Multidimensional exploration of hydrogels as biological scaffolds for spinal cord regeneration: mechanisms and future perspectives. Frontiers in bioengineering and biotechnology. 13, 1576524. DOI: https://doi.org/10.3389/fbioe.2025.1576524

[53] Dave, R., Pandey, K., Patel, R., et al., 2025. Biological Scaffolds in 3D Cell Models: Driving Innovation in Drug Discovery. Stem cell reviews and reports. 21(1), 147–166. DOI: https://doi.org/10.1007/s12015-024-10800-9

[54] Tang, C., Jin, C., Du, X., et al., 2014. An autologous bone marrow mesenchymal stem cell-derived extracellular matrix scaffold applied with bone marrow stimulation for cartilage repair. Tissue engineering: Part A. 20(17–18), 2455–2462. DOI: https://doi.org/10.1089/ten.TEA.2013.0464

[55] Rafieyan, S., Ansari, E., Vasheghani-Farahani, E., 2024. A practical machine learning approach for predicting the quality of 3D (bio)printed scaffolds. Biofabrication. 16(4). DOI: https://doi.org/10.1088/1758-5090/ad6374

[56] Moradi, S., Alizadeh, R., Yazdian, F., et al., 2022. A TGF-α and TGF-β1 Poloxamer-based micelle/hydrogel composite: A promising novel candidate for the treatment of anosmia. Biotechnology progress. 38(6), e3294. DOI: https://doi.org/10.1002/btpr.3294

[57] Oncu, E., Usta Ayanoglu, K.Y., Ciftci, F., 2025. Comparative analysis of deep learning models for predicting biocompatibility in tissue scaffold images. Computers in biology and medicine. 192(Pt A), 110281. DOI: https://doi.org/10.1016/j.compbiomed.2025.110281

Downloads

How to Cite

ahmed, Schank, J., Rohn, M. M., Khan, A. S., Hantash, E. M., & Mathew, L. S. (2025). Tissue-Engineered Neural Stem Cell Scaffolds in Spinal Cord Injury: Insights into Materials, Molecular Pathways, and Regenerative Applications. Journal of Stem Cell Bioengineering, 1(1), 1–17. https://doi.org/10.30564/jscb.v1i1.9529

Issue

Vol. 1 , Iss. 1 (June 2025)

Article Type

Article

License

Copyright © 2025 Ahmed S. Ashour, Jim Schank , Mark M. Rohn, Asim S. Khan, Ehab M. Hantash, Liju S. Mathew

Creative Commons License

This is an open access article under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) License.